Cardinal Health Future Growth
Future criteria checks 2/6
Cardinal Health is forecast to grow earnings and revenue by 7.7% and 5.7% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 2245.9% in 3 years.
Key information
7.7%
Earnings growth rate
10.2%
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | 5.7% |
Future return on equity | 2,245.9% |
Analyst coverage | Good |
Last updated | 19 Nov 2024 |
Recent future growth updates
Results: Cardinal Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 05Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Recent updates
Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056
Nov 09Results: Cardinal Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 05Cardinal Health Q1 Earnings: Margins Signal More Upside
Nov 04Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
Sep 24Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching
Sep 17Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Investors Aren't Entirely Convinced By Cardinal Health, Inc.'s (NYSE:CAH) Revenues
Dec 28Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health, Inc. (NYSE:CAH) Shares Could Be 45% Below Their Intrinsic Value Estimate
Nov 03Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health (NYSE:CAH) Shareholders Will Want The ROCE Trajectory To Continue
Aug 05An Intrinsic Calculation For Cardinal Health, Inc. (NYSE:CAH) Suggests It's 45% Undervalued
Jul 14Cardinal Health: Not A Long-Term Investment
May 24The Return Trends At Cardinal Health (NYSE:CAH) Look Promising
Apr 17Cardinal Health, Inc.'s (NYSE:CAH) Intrinsic Value Is Potentially 78% Above Its Share Price
Mar 30Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.4957
Feb 16Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.4957
Dec 20Aaron Alt is the new finance chief at Cardinal health
Dec 19Is There An Opportunity With Cardinal Health, Inc.'s (NYSE:CAH) 44% Undervaluation?
Dec 14Cardinal Health (NYSE:CAH) Is Paying Out A Dividend Of $0.4957
Nov 16Cardinal Health: Investable In Potential Pullback Despite Weak Medical Segment
Nov 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2027 | 254,740 | 1,702 | 2,232 | 2,800 | 9 |
6/30/2026 | 237,410 | 1,684 | 2,097 | 2,648 | 15 |
6/30/2025 | 219,242 | 1,563 | 1,198 | 1,840 | 15 |
9/30/2024 | 224,454 | 1,280 | 1,078 | 1,587 | N/A |
6/30/2024 | 226,827 | 852 | 3,251 | 3,762 | N/A |
3/31/2024 | 220,426 | 604 | 1,996 | 2,531 | N/A |
12/31/2023 | 216,002 | 691 | 3,409 | 3,941 | N/A |
9/30/2023 | 210,026 | 208 | 2,846 | 3,349 | N/A |
6/30/2023 | 204,979 | 330 | 2,363 | 2,844 | N/A |
3/31/2023 | 198,662 | 463 | 4,545 | 4,973 | N/A |
12/31/2022 | 193,011 | -1,273 | 2,792 | 3,193 | N/A |
9/30/2022 | 186,999 | -1,094 | 3,401 | 3,791 | N/A |
6/30/2022 | 181,326 | -938 | 2,788 | 3,175 | N/A |
3/31/2022 | 176,847 | -955 | 446 | 795 | N/A |
12/31/2021 | 171,286 | 555 | 1,124 | 1,491 | N/A |
9/30/2021 | 167,370 | 1,135 | 1,124 | 1,513 | N/A |
6/30/2021 | 162,467 | 611 | 2,029 | 2,429 | N/A |
3/31/2021 | 156,570 | 1,151 | 1,594 | 2,004 | N/A |
12/31/2020 | 156,452 | 1,382 | 3,003 | 3,403 | N/A |
9/30/2020 | 154,646 | 973 | 2,502 | 2,883 | N/A |
6/30/2020 | 152,922 | -3,696 | 1,585 | 1,960 | N/A |
3/31/2020 | 153,586 | -4,158 | 1,851 | 2,226 | N/A |
12/31/2019 | 149,657 | -4,212 | 1,669 | 2,030 | N/A |
9/30/2019 | 147,662 | -4,152 | 1,362 | 1,704 | N/A |
6/30/2019 | 145,534 | 1,363 | 2,394 | 2,722 | N/A |
3/31/2019 | 143,530 | 3 | 2,440 | 2,770 | N/A |
12/31/2018 | 141,935 | -39 | 1,712 | 2,044 | N/A |
9/30/2018 | 139,381 | 734 | 1,577 | 1,952 | N/A |
6/30/2018 | 136,809 | 256 | N/A | 2,768 | N/A |
3/31/2018 | 134,426 | 1,696 | N/A | 2,938 | N/A |
12/31/2017 | 132,614 | 1,823 | N/A | 1,986 | N/A |
9/30/2017 | 130,578 | 1,094 | N/A | 2,261 | N/A |
6/30/2017 | 129,976 | 1,288 | N/A | 1,184 | N/A |
3/31/2017 | 128,394 | 1,346 | N/A | 1,101 | N/A |
12/31/2016 | 127,236 | 1,351 | N/A | 2,218 | N/A |
9/30/2016 | 125,530 | 1,353 | N/A | 3,127 | N/A |
6/30/2016 | 121,546 | 1,427 | N/A | 2,971 | N/A |
3/31/2016 | 117,710 | 1,387 | N/A | 3,198 | N/A |
12/31/2015 | 112,423 | 1,366 | N/A | 2,937 | N/A |
9/30/2015 | 106,516 | 1,329 | N/A | 2,427 | N/A |
6/30/2015 | 102,531 | 1,212 | N/A | 2,540 | N/A |
3/31/2015 | 97,877 | 1,154 | N/A | 2,388 | N/A |
12/31/2014 | 93,928 | 1,104 | N/A | 2,550 | N/A |
9/30/2014 | 90,631 | 1,089 | N/A | 1,634 | N/A |
6/30/2014 | 91,084 | 1,163 | N/A | 2,524 | N/A |
3/31/2014 | 93,610 | 343 | N/A | 2,108 | N/A |
12/31/2013 | 96,735 | 374 | N/A | 2,277 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CAH's forecast earnings growth (7.7% per year) is above the savings rate (2.6%).
Earnings vs Market: CAH's earnings (7.7% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: CAH's earnings are forecast to grow, but not significantly.
Revenue vs Market: CAH's revenue (5.7% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: CAH's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CAH's Return on Equity is forecast to be very high in 3 years time (2245.9%).